TARDBP and proteostasis deficiencies: Further implicating Ataxin-2 in ALS, antisense oligonucleotides (ASOs) or RNAi targeting ATXN-2 mRNA provide marked protection against motor deficits in mouse models of TDP-43 proteinopathy [9, 11] and SCA2 [13].